Pancreatic Cancer Research

Clinical trialPhase 3Unknown

Simultaneous Resection of Pancreatic Cancer and Liver Oligometastasis After Induction Chemotherapy

NCT03398291↗ ClinicalTrials.gov, retrieved 6 November 2026

Outcome
Outcome unknown
Phase
Phase 3
Status
Unknown
Study type
Interventional
Start
1 July 2018
Expected end
1 June 2025
Enrollment
300 participants
Sites
1
Primary outcomes
Real overall survival
Sponsor
Other
Results posted
No
Last update
9 October 2018

These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

This study is a multi-center phase 3 trial to evaluate a treatment strategy for selecting patients who can benefit from the synchronous resection of primary pancreatic cancer and liver oligometastasis after induction chemotherapy. Half of participants who meet the entry criterion will receive surgical intervention, while the other half will continue to receive standard chemotherapy.

Papers 5